IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vida Ventures Advisors, LLC

Q1 2022 Holdings

Filed 2022-05-04 | 8 holdings | $16.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Allogene Therapeutics, Inc.(ALLO)Common Stock019770106$16.4M1,798,16399.1%
Centessa Pharmaceuticals plc(CNTA)Ordinary Shares152309100$35.3K3,931,8180.2%
Kinnate Biopharma, Inc.Common Stock49705R105$30.9K2,747,4330.2%
Praxis Precision Medicines, Inc.Common Stock74006W108$30.0K2,939,3290.2%
Dyne Therapeutics, Inc.(DYN)Common Stock26818M108$28.5K2,960,0460.2%
Kronos Bio, Inc.(KRON1USD)Common Stock50107A104$20.0K2,765,3140.1%
LianBioOrdinary Shares53000N108$8.5K2,282,0840.1%
Homology Medicines, Inc.Common Stock438083107$2.3K770,8450.0%